Irwin Naturals Inc.(OTCQB:IWINF) (CSE:IWIN) (FRA:97X), has entered into anon-binding amended and restated letter of intentfor abusiness combinationwithBraxia Scientific Corp.(OTCPK:BRAXF) (CSE:BRAX) (FWB:4960), a medical research company providing psychiatric, innovativeketamine and psilocybin treatmentsfor mental health disorders. The LOI sets forth the material terms and conditions upon which Irwin will acquire all of the issued and outstanding common shares of Braxia.

Under the terms of the LOI, Irwin is prepared to offer a purchase price per Braxia share based upon a valuation of the outstanding Braxia shares of$30 million...